O	0	1	C	C	NN	B-NP
O	1	2	/	/	SYM	I-NP
O	2	9	EBPbeta	EBPbeta	NN	I-NP
O	10	12	is	be	VBZ	B-VP
O	13	17	over	over	RB	B-ADVP
O	17	18	-	-	HYPH	B-NP
O	18	27	expressed	express	VBN	B-VP
O	28	30	in	in	IN	B-PP
B-Organ	31	38	gastric	gastric	JJ	B-NP
O	39	53	carcinogenesis	carcinogenesis	NN	I-NP
O	54	57	and	and	CC	O
O	58	60	is	be	VBZ	B-VP
O	61	71	associated	associate	VBN	I-VP
O	72	76	with	with	IN	B-PP
O	77	80	COX	COX	NN	B-NP
O	80	81	-	-	HYPH	O
O	81	82	2	2	CD	B-NP
O	83	93	expression	expression	NN	I-NP
O	93	94	.	.	.	O

O	96	99	The	The	DT	B-NP
O	100	105	CCAAT	CCAAT	NN	I-NP
O	105	106	/	/	SYM	B-NP
O	106	114	enhancer	enhancer	NN	I-NP
O	114	115	-	-	HYPH	O
O	115	122	binding	bind	VBG	B-VP
O	123	130	protein	protein	NN	B-NP
O	131	135	beta	beta	NN	I-NP
O	136	137	(	(	(	O
O	137	138	C	C	NN	B-NP
O	138	139	/	/	SYM	B-NP
O	139	146	EBPbeta	EBPbeta	NN	I-NP
O	146	147	)	)	)	O
O	148	161	transcription	transcription	NN	B-NP
O	162	168	factor	factor	NN	I-NP
O	169	172	has	have	VBZ	B-VP
O	173	177	been	be	VBN	I-VP
O	178	188	associated	associate	VBN	I-VP
O	189	193	with	with	IN	B-PP
O	194	201	several	several	JJ	B-NP
B-Cancer	202	208	cancer	cancer	NN	I-NP
O	209	215	models	model	NNS	I-NP
O	215	216	.	.	.	O

O	217	219	In	In	IN	B-PP
O	220	224	this	this	DT	B-NP
O	225	230	study	study	NN	I-NP
O	230	231	,	,	,	O
O	232	235	the	the	DT	B-NP
O	236	246	expression	expression	NN	I-NP
O	247	249	of	of	IN	B-PP
O	250	251	C	C	NN	B-NP
O	251	252	/	/	SYM	B-NP
O	252	259	EBPbeta	EBPbeta	NN	I-NP
O	260	263	was	be	VBD	B-VP
O	264	272	analysed	analyse	VBN	I-VP
O	273	275	in	in	IN	B-PP
O	276	277	a	a	DT	B-NP
O	278	284	series	series	NN	I-NP
O	285	287	of	of	IN	B-PP
O	288	290	90	90	CD	B-NP
B-Cancer	291	298	gastric	gastric	JJ	I-NP
I-Cancer	299	309	carcinomas	carcinoma	NNS	I-NP
O	310	311	(	(	(	O
B-Cancer	311	314	GCs	GC	NNS	B-NP
O	314	315	)	)	)	O
O	315	316	.	.	.	O

O	317	319	We	We	PRP	B-NP
O	320	324	also	also	RB	B-ADVP
O	325	333	assessed	assess	VBD	B-VP
O	334	337	the	the	DT	B-NP
O	338	344	effect	effect	NN	I-NP
O	345	347	of	of	IN	B-PP
O	348	349	C	C	NN	B-NP
O	349	350	/	/	SYM	I-NP
O	350	357	EBPbeta	EBPbeta	NN	I-NP
O	358	360	on	on	IN	B-PP
O	361	364	COX	COX	NN	B-NP
O	364	365	-	-	HYPH	O
O	365	366	2	2	CD	B-NP
O	367	377	expression	expression	NN	I-NP
O	377	378	.	.	.	O

O	379	381	In	In	IN	B-PP
O	382	388	normal	normal	JJ	B-NP
B-Multi-tissue_structure	389	396	gastric	gastric	JJ	I-NP
I-Multi-tissue_structure	397	403	mucosa	mucosa	NN	I-NP
O	403	404	,	,	,	O
O	405	406	C	C	NN	B-NP
O	406	407	/	/	SYM	B-VP
O	407	414	EBPbeta	EBPbeta	NN	B-NP
O	415	425	expression	expression	NN	I-NP
O	426	429	was	be	VBD	B-VP
O	430	440	restricted	restricted	JJ	B-ADJP
O	441	443	to	to	TO	B-PP
B-Cell	444	449	cells	cell	NNS	B-NP
O	450	452	in	in	IN	B-PP
O	453	456	the	the	DT	B-NP
O	457	470	proliferative	proliferative	JJ	I-NP
B-Cell	471	475	zone	zone	NN	I-NP
O	475	476	.	.	.	O

O	477	479	In	In	IN	B-PP
B-Pathological_formation	480	490	intestinal	intestinal	JJ	B-NP
I-Pathological_formation	491	501	metaplasia	metaplasia	NN	I-NP
O	501	502	,	,	,	O
B-Pathological_formation	503	512	dysplasia	dysplasia	NN	B-NP
O	512	513	,	,	,	O
O	514	517	and	and	CC	O
B-Cancer	518	520	GC	GC	NN	B-NP
O	521	523	of	of	IN	B-PP
O	524	527	the	the	DT	B-NP
B-Multi-tissue_structure	528	538	intestinal	intestinal	JJ	I-NP
O	539	542	and	and	CC	I-NP
O	543	551	atypical	atypical	JJ	I-NP
O	552	560	subtypes	subtype	NNS	I-NP
O	560	561	,	,	,	O
O	562	563	C	C	NN	B-NP
O	563	564	/	/	SYM	B-NP
O	564	571	EBPbeta	EBPbeta	NN	I-NP
O	572	575	was	be	VBD	B-VP
O	576	580	over	over	RB	B-ADVP
O	580	581	-	-	HYPH	O
O	581	590	expressed	express	VBN	B-VP
O	591	592	(	(	(	O
O	592	593	p	p	NN	B-NP
O	594	595	<	<	SYM	B-ADJP
O	596	597	0	0	CD	B-NP
O	597	598	.	.	.	I-NP
O	598	602	0001	0001	CD	I-NP
O	602	603	,	,	,	O
O	604	607	for	for	IN	B-PP
O	608	611	the	the	DT	B-NP
O	612	623	association	association	NN	I-NP
O	624	628	with	with	IN	B-PP
O	629	641	histological	histological	JJ	B-NP
O	642	646	type	type	NN	I-NP
O	646	647	)	)	)	O
O	647	648	.	.	.	O

O	649	650	C	C	NN	B-NP
O	650	651	/	/	SYM	I-NP
O	651	658	EBPbeta	EBPbeta	NN	I-NP
O	659	662	and	and	CC	I-NP
O	663	667	Ki67	Ki67	NN	I-NP
O	667	668	,	,	,	O
O	669	670	a	a	DT	B-NP
O	671	677	marker	marker	NN	I-NP
O	678	680	of	of	IN	B-PP
B-Cell	681	685	cell	cell	NN	B-NP
O	686	699	proliferation	proliferation	NN	I-NP
O	699	700	,	,	,	O
O	701	705	were	be	VBD	B-VP
O	706	710	also	also	RB	B-ADVP
O	711	713	co	co	AFX	B-ADJP
O	713	714	-	-	HYPH	B-NP
O	714	723	expressed	express	VBN	B-VP
O	724	726	in	in	IN	B-PP
B-Cancer	727	734	primary	primary	JJ	B-NP
I-Cancer	735	737	GC	GC	NN	I-NP
O	737	738	.	.	.	O

O	739	741	We	We	PRP	B-NP
O	742	746	also	also	RB	B-ADVP
O	747	755	observed	observe	VBD	B-VP
O	756	758	an	an	DT	B-NP
O	759	766	overlap	overlap	NN	I-NP
O	767	774	between	between	IN	B-PP
O	775	776	C	C	NN	B-NP
O	776	777	/	/	SYM	B-NP
O	777	784	EBPbeta	EBPbeta	NN	I-NP
O	785	788	and	and	CC	I-NP
O	789	792	COX	COX	NN	I-NP
O	792	793	-	-	HYPH	O
O	793	794	2	2	CD	B-NP
O	795	805	expression	expression	NN	I-NP
O	806	808	in	in	IN	B-PP
B-Cancer	809	811	GC	GC	NN	B-NP
O	811	812	.	.	.	O

O	813	818	Using	Use	VBG	B-VP
B-Cell	819	821	GC	GC	NN	B-NP
I-Cell	822	826	cell	cell	NN	I-NP
I-Cell	827	832	lines	line	NNS	I-NP
O	833	835	we	we	PRP	B-NP
O	836	840	show	show	VBP	B-VP
O	841	845	that	that	IN	B-SBAR
O	846	847	C	C	NN	B-NP
O	847	848	/	/	SYM	B-NP
O	848	855	EBPbeta	EBPbeta	NN	I-NP
O	856	859	can	can	MD	B-VP
O	860	868	regulate	regulate	VB	I-VP
O	869	872	the	the	DT	B-NP
O	873	883	expression	expression	NN	I-NP
O	884	886	of	of	IN	B-PP
O	887	897	endogenous	endogenous	JJ	B-NP
O	898	901	COX	COX	NN	I-NP
O	901	902	-	-	HYPH	B-NP
O	902	903	2	2	CD	I-NP
O	904	907	and	and	CC	O
O	908	921	transactivate	transactivate	VB	B-VP
O	922	925	the	the	DT	B-NP
O	926	934	promoter	promoter	NN	I-NP
O	935	937	of	of	IN	B-PP
O	938	941	the	the	DT	B-NP
O	942	945	COX	COX	NN	I-NP
O	945	946	-	-	HYPH	B-NP
O	946	947	2	2	CD	I-NP
O	948	952	gene	gene	NN	I-NP
O	952	953	,	,	,	O
O	954	963	depending	depend	VBG	B-PP
O	964	966	on	on	IN	B-PP
O	967	970	its	its	PRP$	B-NP
O	971	982	methylation	methylation	NN	I-NP
O	983	989	status	status	NN	I-NP
O	989	990	.	.	.	O

O	991	996	These	These	DT	B-NP
O	997	1004	results	result	NNS	I-NP
O	1005	1012	suggest	suggest	VBP	B-VP
O	1013	1017	that	that	IN	B-SBAR
O	1018	1019	C	C	NN	B-NP
O	1019	1020	/	/	SYM	B-NP
O	1020	1027	EBPbeta	EBPbeta	NN	I-NP
O	1028	1031	may	may	MD	B-VP
O	1032	1034	be	be	VB	I-VP
O	1035	1036	a	a	DT	B-NP
O	1037	1043	marker	marker	NN	I-NP
O	1044	1046	of	of	IN	B-PP
B-Cancer	1047	1057	neoplastic	neoplastic	JJ	B-NP
O	1058	1072	transformation	transformation	NN	I-NP
O	1073	1076	and	and	CC	O
O	1077	1081	also	also	RB	B-VP
O	1082	1086	play	play	VBP	I-VP
O	1087	1089	an	an	DT	B-NP
O	1090	1096	active	active	JJ	I-NP
O	1097	1101	role	role	NN	I-NP
O	1102	1104	in	in	IN	B-PP
B-Organ	1105	1112	gastric	gastric	JJ	B-NP
O	1113	1127	tumourigenesis	tumourigenesis	NN	I-NP
O	1128	1130	by	by	IN	B-PP
O	1131	1141	regulating	regulate	VBG	B-VP
O	1142	1145	COX	COX	NN	B-NP
O	1145	1146	-	-	HYPH	O
O	1146	1147	2	2	CD	B-NP
O	1148	1158	expression	expression	NN	I-NP
O	1158	1159	.	.	.	O

